27 February 2012
People with serious heart problems were less likely to suffer from depression if they took cholesterol-lowering statins during their treatment process.
This is one of the main findings of research led by Mary Whooley, a physician at the San Francisco VA Medical Center and a professor of medicine at the University of California.
Ms Whooley and a team of researchers studied 965 heart disease patients for any signs of depression during their treatment of the condition.
Of these patients, those given cholesterol-lowering statins were considerably less likely to suffer from clinical depression than those who were treated without the statins.
The researchers then studied the 776 patients who were not originally depressed and found that the 28 per cent who were not given statins during their treatment developed depression over the next six years.
In comparison, only 18.5 per cent of those on the drugs suffered from depression over the same time.
The research findings were released soon after University of Nottingham scientists unveiled its mathematical model of the human heart, in a development which the team hopes will lead to better methods of combating a wide collection of heart problems.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.